Literature DB >> 33263701

Mycobacterium marinum infection simulating chromomycosis: a case report.

Guilherme Holanda Bezerra1, Monica Larissa Padilha Honório1, Vivianne Lira da Camara Costa1, Hareton Teixeira Vechi1, Manoella do Monte Alves1, Maria Helena Marques Fonseca de Britto1, Keyla Borges Ferreira Rocha1, Luciana Distásio de Carvalho2.   

Abstract

Skins infections caused by Mycobacterium marinum occur only rarely. We report one case of chronic and extensive M. marinum cutaneous infection simulating chromoblastomycosis and review the pertinent literature. A 52-year-old farmer reported a 32-year chronic skin problem on his right lower limb, resulting from contact with cacti. It consisted of skin lesion presenting with dyschromic atrophic center plate and verrucous borders with hematic crusts, extending from the knee anteriorly to the inferior third of the right leg. Mycobacterium marinum infection was detected by histopathological examination of a skin fragment, culture for mycobacteria and genetic mapping of the culture material. The patient was successfully treated with Ethambutol, Rifampicin and Trimethoprim-Sulfamethoxazole. The clinical and histopathological findings of M. marinum infection is nonspecific showing clinical polymorphism and bacilli are rarely evident on histopathological examination. Given these difficulties, it is essential to perform tissue culture in a suspicious case and it is important keep this infection in mind in patients with long-lasting indolent verrucous lesions and a history of exposure to sea water, freshwater, aquaria or fish.

Entities:  

Year:  2020        PMID: 33263701      PMCID: PMC7694539          DOI: 10.1590/S1678-9946202062095

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN: 0036-4665            Impact factor:   1.846


INTRODUCTION

Cutaneous infections caused by Mycobacterium marinum (Mma), a member of the nontuberculous mycobacteria (NTM) group, is a rare disease. M. marinum virtually always causes cutaneous disease through direct inoculation, typically following traumatic injuries caused by a contaminated environmental source , . The manifestations include granulomatous lesions, predominantly acral in distribution, that affect patients regardless of their immune status. Clinical and histopathological findings are non-specific, consisting of papules, nodules or erythematous plaquesand the presence of tuberculous granulomas with little evidence of bacilli on examination. Due to diagnostic difficulties, going from the infrequent distribution and the plurality of clinical presentations, M. marinum can cause erythematous to plate-shaped, papules, nodules, single or multiple ulcerations and even sporotrichosis-like presentations, making the differential diagnosis with other granulomatous lesions essential . The infection in humans, due to contact with contaminated water or fish is comparatively rare with an incidence of 0.04 to 0.27 cases per 100,000 inhabitants per year . First described as a “swimming-pool granuloma”, M. marinum skin infection is nowadays acquired in the maintenance of aquariums and, therefore, is called “fish tank granuloma” or aquarium granuloma . Mycobacterium marinum is an acid-fast, aerobic, not mobile, non-sporulating, photochromogen bacterium with a thick cell wall made up of wax (40-70%) and lipids (25-30%). Mycobacterium marinum growth is usually slow, takingtwo to six weeks on Lowenstein–Jensen medium at 25-33 °C. By using light source in culture, the color changes from white to yellow because of the accumulation of β-carotene crystals. It has a worldwide diffusion, mainly in temperate and hot-humid climate, living in aquatic environments, especially in salt water and aquariums or pools , . This mycobacterium can infect cold-blooded animals such as turtles, amphibians and snakes, causing chronic systemic infection in fish , . Dead fish can serve, as well, as reservoirs , . The diagnosis can be made by histological examination and identification of M. marinum in a culture of a fragment of a lesion fragment sown in Löwenstein-Jensen medium. The organisms isolated from the lesion, as well as from the patient's colonies are smooth, shiny and creamy colored, turning yellow under exposure to light (photochromogenic). Faster identification may be achieved by the polymerase chain reaction . Dermatoscopic characteristics of a microbiologically-proven M. marinum skin infection can be used in the future to establish very early diagnosis of this infection, reducing the diagnostic delay . Here we report one case of atypical M. marinum cutaneous infection from an injury caused by contact with a cactus and review the pertinent literature.

CASE REPORT

A 52-year-old black male farmer from a rural area in Northeastern Brazil was referred to our outpatient infectious diseases clinic because of skin plaques after a trauma caused by a cactus thorn on his right leg 32 years before. He was otherwise healthy and mentioned bathing in ponds, fishing activities and handling fish for his own consumption. The plaque had a dyschromic atrophic center and erythematous-violaceous infiltrated verrucous borders with hematic crusts extending anteriorly from the upper border of the right knee to the lower third of the right leg ( Figures 1A and 1B ). He denied systemic symptoms, renal and hepatic functions, blood countand lipid profiles were within normal limits. A skin ellipse biopsy of the right leg was performed and showed a chronic inflammatory process in the superficial and deep dermis associated with pseudo-epitheliomatous hyperplasia ( Figures 2A and 2B ). Direct search for fungus and mycobacteria with Periodic acid-Schhiff (PAS) and Fite-Faraco, respectively, were negative ( Figure 2C ). A fungal culture was also negative. A mycobacteria culture in Ogawa Kudoh medium was positive ( Figure 3 ) and M. marinum was identified through a Polymerase Chain Reaction (PCR) followed by a Restriction Enzyme Analysis (REA).
Figure 1

Erythematous-violaceous infiltrated verrucous borders lesion with hematic crusts extending anteriorly from the upper border of the right knee to the lower third of the right leg (A) and a plaque with a dyschromic atrophic center (B). Regression of cutaneous lesions six months after the beginning of treatment with an atrophic plaque in the entire region, previously affected, on right lower limb (C).

Figure 2

Chronic inflammatory process in the superficial and deep dermis associated with pseudo-epitheliomatous hyperplasia with negative Periodic acid-Schhiff (PAS) (A, B). Acid-fast Bacilli (AFB) by Fite-Faraco negative to mycobacteria (C).

Figure 3

Biopsy culture in Ogawa Kudoh medium culture showing colonies of M. marinum.

The patient received a combined treatment for six months composed of ethambutol 400 mg three times a day for three months, rifampicin 300 mg twice daily for six months and trimethoprim-sulfamethoxazole (160 mg + 800 mg) twice daily for six months; topical treatment was not performed. The verrucous lesions disappeared ( Figure 1C ), leaving a dystrophic atrophic plaque in the affected region, with no relapse to date.

DISCUSSION

The genus Mycobacterium comprises more than 177 species including pathogenic, opportunistic pathogens and non-pathogenic environmental species, most of which have been incriminated in skin and soft tissues infections. Mycobacteria are free-living, acid-fast, robust organisms that can survive and even thrive in widely diverse environments such as soil and tap water to animals and humans consumption. Of interest to this study, M. marinum was first described in 1926 by Joseph D. Aronson. The bacterium was isolated from fish presenting with mycobacteriosis infection and exhibiting similarities with tuberculosis in humans. Later, it was shown that M. marinum could also infect humans and cause skin lesions at the extremities of the limbs . Scientific interest in M. marinum is mainly due to its genetic relatedness to M. tuberculosis , and it is a model for tuberculosis pathogenesis . The retrospective study in Denmark performed from January 1st, 2004 to May 31st, 2017 identified 55 patients with culture-positive M. marinum infections. Men comprised 71.7% of patients with a median age of 49 years. Almost all patients had a history of aquatic exposure, predominately the maintenance of fish tank Mycobacterium marinum infection usually occurs in immunocompetent patients with minor trauma followed by contact with an infected animal or handling of contaminated aquariums or water . In immunocompetent patients lesions are usually solitary, a red-to-violaceous plaque or nodule with an overlying crust or verrucous surface that may ulcerate. Inflammatory nodules or abscesses can develop in severely immunosuppressed patient, usually in a type of distribution of sporotrichosis . Our patient had been injured via puncture by a cactus spine to the knee. M. marinum can also cause an opportunistic infection, primarily in immune deficient patients, such as those with the human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS). Mycobacterium marinum infection has polymorphic clinical presentations. Initially, a solitary erythematous papule or nodule will appear at the site of inoculation, often on an extremity, particularly the hand. This can progress to a verrucous violaceus plaque and/or ulcerate lesion producing a serosanguineous discharge, and in 29% of the cases, bacteria can invade deeper tissues, such as tendon sheaths, bursae, bones and joints. There a are four clinical categories according to the severity of infections: localized superficial cutaneous lesions (type I), nodular lymphangitis sometimes with nodules, abscesses and granulomas (type II), deeper infections with or without skin involvement (type III) and M. marinum disseminated infection with lung involvement and other systemic manifestations (type IV). Bacteremia is exceedingly rare but may occur in severely immunocompromised patients. Other sites of M. marinum infection have also been reported. Severe intranasal lesions resulting from M. marinum infections, while the disseminated infection comprises the skin, lungs and other viscera and the larynx , . Our patient had a 32-year history of a large verrucous plaque remarkably similar to chromomycosis. Lillis et al . reported a 29-year-old male South Pacific Islander with an 18-year history of a similar lesion on the left leg, simulating psoriasis, chromomycosis or tuberculosis verrucose cutis. Lee and Brennan published some cases of otherwise healthy South Pacific Islanders with chronic lesions (more than 20 years) of verrucous plaques on the lower extremities. In France, 63 cases of culture-confirmed M. marinum infections were studied from January 1, 1996, to December 31, 1998. Nodules were observed in 41 (67%) of the 63 patients, including a sporotrichoid aspect in 16 (39% of the nodules). Other skin lesions were ulcers, abscesses and pustules. Adenitis was observed in 10 patients . It is noteworthy that the skin lesions caused by M. marinus in our case were not reported in the other case studies, demonstrating that this characteristic is rare. Skin lesions of non-tuberculous mycobacteria often go misdiagnosed. Mycobacterium marinum infection is a diagnosis that must be considered as a differential diagnosis with wart tuberculosis, sporotrichosis, chromomycosis, squamous cell carcinoma, leishmaniasis, tularemia, sarcoidosis and reactions to foreign bodies, as the growth of mycobacterium marinus is slow, delaying the diagnosis and treatment . As our case shows, the same immunocompetent patient suffered 32 years with the infection and had a considerable delay in the diagnosis. A delay between the onset of injuries and the patient's seeking medical attention is due to the fact that the infection is indolent, and the lesions are painless. The diagnosis of M. marinum infection is often delayed, due to its low prevalence and because there are few specific clinical signs and symptoms. Thus, many patients initially receive incorrect diagnoses and inappropriate treatments . Biopsies for tissue cultures and histopathologic examination are essential for the diagnosis . Common histopathological patterns include granulomatous inflammatory infiltrates. Microscopic examination of the specimen after Ziehl-Neelsen staining is positive in 30% of the cases. A definitive diagnosis is obtained by the finding of a positive culture that occurs in 70-80% of the cases. After isolation of a photochromogenic Mycobacterium , molecular identification using DNA analysis is necessary . In our case, the REA method was used. PCR amplification and restriction enzyme analysis (PCR-REA), hybridization with species-specific oligonucleotide probes (with or without prior DNA amplification) and nucleic acid sequencing have shown to identify a limited number of Mycobacterium strains . Mycobacterium marinum isolates are susceptible to rifampin, rifabutin and ethambutol; intermediately susceptible to streptomycin; and resistant to isoniazid and pyrazinamide. Isolates are also susceptible to clarithromycin, sulfonamides or trimethoprim sulfamethoxazole, and susceptible or intermediately susceptible to doxycycline and minocycline. A reasonable approach is a treatment regimen composed of two active agents for 1 to 2 months after resolution of symptoms, typically 3 to 4 months. In a French study, the combination of clarithromycin and rifampin for an average of 3.5 months resolved infections in 93% of the patients with localized forms and in 72% of those with deep structure involvement (e.g., osteomyelitis). Treatment failure was related to deep structure involvement, but not to any antibiotic regimen. Clarithromycin and ethambutol are likely to provide the optimal balance of efficacy and tolerability for most patients, with the addition of rifampin in cases of osteomyelitis or other deep structure infection . Experience in treatment of other NTM suggests that azithromycin may be a reasonable alternative to clarithromycin. Susceptibility tests are not routinely recommended and should be reserved for cases of treatment failure. Resection and debridement of the lesion are generally not recommended and are only indicated in cases refractory to treatment with antibiotics. Some studies showed worsening of conditions when resections and debridement were carried out. Evidently, the intervention may be indicated as an adjunctive treatment in cases of tissue necrosis and septic arthritis, facilitating the effects of antibiotics . Cryotherapy, laser and photodynamic therapy have been reported as effective treatment alternatives, but there are few studies evaluating the efficiency of these methods .

CONCLUSION

Mycobacterium marinum is considered an uncommon cause of skin infection in humans. The diagnosis requires a high index of suspicion. This infection should be included in the differential diagnosis of chronic verrucous plaques on the extremities, especially if there is a history of exposure to fresh, salt water or marine animals. Further studies are needed to understand its clinical polymorphism with some patients showing spontaneous cure, while others develop long-term diseases.
  16 in total

Review 1.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

Authors:  David E Griffith; Timothy Aksamit; Barbara A Brown-Elliott; Antonino Catanzaro; Charles Daley; Fred Gordin; Steven M Holland; Robert Horsburgh; Gwen Huitt; Michael F Iademarco; Michael Iseman; Kenneth Olivier; Stephen Ruoss; C Fordham von Reyn; Richard J Wallace; Kevin Winthrop
Journal:  Am J Respir Crit Care Med       Date:  2007-02-15       Impact factor: 21.405

Review 2.  [Mycobacterium marinum infection. Case report and review of the literature].

Authors:  C R García Acebes; L Barchino Ortiz; S Aboín González; B Díaz Ley; P Ruiz Fernández; F Sánchez de Paz
Journal:  Actas Dermosifiliogr       Date:  2006-12

3.  Mycobacterium marinum: chronic and extensive infections of the lower limbs in south Pacific islanders.

Authors:  M W Lee; J Brenan
Journal:  Australas J Dermatol       Date:  1998-08       Impact factor: 2.875

Review 4.  Mycobacterium marinum.

Authors:  Alexandra Aubry; Faiza Mougari; Florence Reibel; Emmanuelle Cambau
Journal:  Microbiol Spectr       Date:  2017-04

5.  Dermoscopy of Mycobacterium marinum Skin infection: A Challenging Diagnosis.

Authors:  Claudio Conforti; Iris Zalaudek; Silvia Vichi; Nicola Di Meo
Journal:  Acta Dermatovenerol Croat       Date:  2019-12       Impact factor: 1.256

6.  Fish tank granuloma caused by Mycobacterium marinum in two aquarists: two case reports.

Authors:  Michal Slany; Petr Jezek; Monika Bodnarova
Journal:  Biomed Res Int       Date:  2013-12-12       Impact factor: 3.411

7.  Mycobacterium marinum infection: a case report.

Authors:  Christiane Salgado Sette; Patrick Alexander Wachholz; Paula Yoshiko Masuda; Renata Borges Fortes da Costa Figueira; Fernanda Rodrigues de Oliveira Mattar; Deise Godoy Ura
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2015-03-20

8.  Amputation of a finger in a patient with multidrug-resistant Mycobacterium marinum skin infection.

Authors:  Stefano Veraldi; Paolo Pontini; Gianluca Nazzaro
Journal:  Infect Drug Resist       Date:  2018-10-30       Impact factor: 4.003

Review 9.  Mycobacterium marinum infection in fish and man: epidemiology, pathophysiology and management; a review.

Authors:  Emad Hashish; Abdallah Merwad; Shimaa Elgaml; Ali Amer; Huda Kamal; Ahmed Elsadek; Ayman Marei; Mahmoud Sitohy
Journal:  Vet Q       Date:  2018-12       Impact factor: 3.320

10.  Atypical clinical and laboratory features of fish-tank granuloma: A case report.

Authors:  Michael Sander; Judith L Isaac-Renton; Megan A Sander
Journal:  SAGE Open Med Case Rep       Date:  2018-10-10
View more
  2 in total

Review 1.  Reviewing the Etiologic Agents, Microbe-Host Relationship, Immune Response, Diagnosis, and Treatment in Chromoblastomycosis.

Authors:  Luiz Felipe Domingues Passero; Italo Novais Cavallone; Walter Belda
Journal:  J Immunol Res       Date:  2021-11-01       Impact factor: 4.818

Review 2.  Mycobacterial skin infection.

Authors:  Giulia Gardini; Natalia Gregori; Alberto Matteelli; Francesco Castelli
Journal:  Curr Opin Infect Dis       Date:  2022-04-01       Impact factor: 4.915

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.